Dear Students, Faculty, and Staff,

As we reflect upon another distinguished year at the DmbH Institute of Medical Science, I am filled with immense pride and gratitude for our vibrant academic community. Together, we have continued to advance the frontiers of medical and pharmaceutical education, maintaining a steadfast commitment to both academic excellence and our broader role in global health.

I am pleased to share several key milestones and upcoming developments that highlight our collective progress:

• Strategic Academic Expansion: We have successfully increased our core student intake from 60 to 100. Furthermore, we are in the final stages of opening four new branches for postgraduate pharmacy courses, each accommodating 16 scholars.
• Accreditation and Quality Assurance: We are firmly on track to achieve NAAC accreditation this year, a milestone that will significantly elevate our institutional standards. Additionally, following our recent QCI inspection, we are highly optimistic about securing an improved institutional ranking.
• Research and Innovation: This year has yielded remarkable breakthroughs in our research initiatives. Through strategic collaborations with leading organizations, we have successfully translated critical research insights into tangible benefits for the communities we serve.
• Pedagogical Excellence: Our faculty has demonstrated an unwavering commitment to nurturing the next generation of healthcare professionals. Through innovative teaching methodologies and hands-on training, we continue to empower our students to become compassionate, skilled, and socially responsible practitioners.
• Infrastructure Upgrades: Our classrooms are currently fully equipped with ICT tools to support modern pedagogy. In the near future, we will roll out comprehensive digital services to foster an even more dynamic and engaging learning environment.

Beyond these achievements, I want to deeply commend the resilience our community has demonstrated in the face of recent challenges. Your dedication—whether adapting to evolving learning formats or contributing to local health initiatives—has been a profound source of inspiration.

Looking ahead, I am excited about our upcoming projects and the immense opportunities for institutional growth. Let us continue to strive for excellence, uphold our core values of integrity and service, and make meaningful contributions to the healthcare sector.

Finally, I extend my heartfelt congratulations to everyone involved in making "HOPE 25" a resounding success, setting a remarkable benchmark for our educational society.

Thank you for your unwavering dedication and for being an integral part of the DmbH Institute of Medical Science family.

Warm regards,
Prof. (Dr.) Prithwiraj Mohapatra
Principal, DmbH Institute of Medical Science